Projects in Progress
Page 1 of 8 (78 results)
-
CDR Review
Actemra
Generic name tocilizumab Brand name Actemra Manufacturer Hoffman-La Roche Ltd. Indication Arthritis, juvenile idiopathic Submission type New Indication Project Number S0267 Date submission received 2012-01-30 Patient input deadline 2012-02-17 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Mozobil
Generic name plerixafor Brand name Mozobil Manufacturer Genzyme Canada Inc. Indication Hematopoietic stem cell mobilizer in non-Hodgkin's lymphoma and multiple myeloma Submission type Initial Project Number SR0265 Date submission received 2012-01-24 Patient input deadline 2012-02-15 SUBMITTING_PATIENT_INPUT Status Active Submission status report Recommendation -
CDR Review
Eliquis
Generic name apixaban Brand name Eliquis Manufacturer Bristol-Myers Squibb and Pfizer Canada Alliance Indication prevention of venous thromboembolic events Submission type Initial Project Number S0264 Date submission received 2011-12-20 Patient input deadline 2012-01-17 Status Active Submission status report Recommendation -
CDR Review
Effient
Generic name prasugrel Brand name Effient Manufacturer Eli Lily Canada Inc. Indication Acute Coronary Syndrome (ACS) Submission type Resubmission #1 Project Number S0263 Date submission received 2011-12-12 Patient input deadline 2012-01-16 Status Active Submission status report Recommendation -
CDR Review
Saphris
Generic name Asenapine Brand name Saphris Manufacturer Lundbeck Canada Inc. Indication Bipolar 1 and schizophrenia Submission type Initial Project Number S0262 Date submission received 2011-12-12 Patient input deadline 2012-01-09 Status Active Submission status report Recommendation -
Projects In Progress
Ultraviolet Light for the Disinfection of Ultrasound Probes Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Project Type: Summary of Abstracts
-
Projects In Progress
Ultraviolet Light for the Disinfection of Ultrasound Probes Clinical Effectiveness, Cost-Effectiveness, and Guidelines
Project Type: Summary of Abstracts
-
Projects In Progress
Celecoxib versus Non-COX-2 Selective Non-steroidal Anti-inflammatory Drugs and Proton Pump Inhibitors: A Review of the Clinical Effectiveness, Safety, and Cost Effectiveness
Project Type: Summary with Critical Appraisal
-
Projects In Progress
Celecoxib versus Non-COX-2 Selective Non-steroidal Anti-inflammatory Drugs: A Review of the Clinical Effectiveness, Safety, and Cost Effectiveness
Project Type: Summary with Critical Appraisal
-
Projects In Progress
Celecoxib versus Non-COX-2 Selective Non-steroidal Anti-inflammatory Drugs and Proton Pump Inhibitors: A Review of the Clinical Effectiveness, Safety, and Cost Effectiveness
Project Type: Summary with Critical Appraisal